Improving quality of care and clinical outcomes for rectal cancer through clinical audits in a multicentre cancer care organisation

dc.contributor.authorTorras, M. G.
dc.contributor.authorCanals, E.
dc.contributor.authorMuñoz Montplet, C.
dc.contributor.authorVidal, A.
dc.contributor.authorJurado, D.
dc.contributor.authorEraso Urién, Arantxa
dc.contributor.authorVillà, S.
dc.contributor.authorCaro, M.
dc.contributor.authorMolero, J.
dc.contributor.authorMacià, M.
dc.contributor.authorPuigdemont, M.
dc.contributor.authorGonzález Muñoz, Elena
dc.contributor.authorGuedea Edo, Ferran
dc.contributor.authorBorràs Andrés, Josep Maria
dc.date.accessioned2021-01-21T13:55:47Z
dc.date.available2021-01-21T13:55:47Z
dc.date.issued2020
dc.date.updated2021-01-21T13:55:47Z
dc.description.abstractIntroduction: Colorectal cancer treatment requires a complex, multidisciplinary approach. Because of the potential variability, monitoring through clinical audits is advisable. This study assesses the effects of a quality improvement action plan in patients with locally advanced rectal cancer and treated with radiotherapy. Methods: Comparative, multicentre study in two cohorts of 120 patients each, selected randomly from patients diagnosed with rectal cancer who had initiated radiotherapy with a curative intent. Based on the results from a baseline clinical audit in 2013, a quality improvement action plan was designed and implemented; a second audit in 2017 evaluated its impact. Results: Standardised information was present on 77.5% of the magnetic resonance imaging (MRI) staging reports. Treatment strategies were similar in all three study centres. Of the patients whose treatment was interrupted, just 9.7% received a compensation dose. There was an increase in MRI re-staging from 32.5 to 61.5%, and a significant decrease in unreported circumferential resection margins following neoadjuvant therapy (ypCRM), from 34.5 to 5.6% (p < 0.001). Conclusions: The comparison between two clinical audits showed improvements in neoadjuvant radiotherapy in rectal cancer patients. Some indicators reveal areas in need of additional efforts, for example to reduce the overall treatment time.
dc.format.extent9 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec696254
dc.identifier.issn1748-717X
dc.identifier.pmid32005123
dc.identifier.urihttps://hdl.handle.net/2445/173322
dc.language.isoeng
dc.publisherBioMed Central
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1186/S13014-020-1465-z
dc.relation.ispartofRadiation Oncology, 2020, vol. 15
dc.relation.urihttps://doi.org/10.1186/S13014-020-1465-z
dc.rightscc-by (c) Torra, M. G. et al., 2020
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Ciències Clíniques)
dc.subject.classificationCàncer colorectal
dc.subject.classificationRadioteràpia
dc.subject.otherColorectal cancer
dc.subject.otherRadiotherapy
dc.titleImproving quality of care and clinical outcomes for rectal cancer through clinical audits in a multicentre cancer care organisation
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
696254.pdf
Mida:
540.94 KB
Format:
Adobe Portable Document Format